Rankings
▼
Calendar
AMRN Q3 2016 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$338M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
Gross Profit
$24M
74.2% margin
Operating Income
-$15M
-46.6% margin
Net Income
-$16M
-48.2% margin
EPS (Diluted)
$-1.51
QoQ Revenue Growth
-1.1%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$194M
Total Liabilities
$179M
Stockholders' Equity
$15M
Cash & Equivalents
$118M
← FY 2016
All Quarters
Q4 2016 →